Stock screenerAll disclosures →
EDGAR →
LQDA
Conviction 100HealthcareScan · Thu, Jun 25, 2026LQDA$76.89+1.79%
ResistanceSupportVol 14Insider buyInsider sell2
2
2
2
4
8
2
2
5
Vol MA14 3.58M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price76.89
Change+1.79%
Gap-0.72%
Rel volume4.22×
Avg volume3.08M
Avg $ vol213.65M
SMA 2066.77
SMA 5054.90
SMA 20037.83
Price vs 50+40.04%
Price vs 200+103.23%
MA stackbullish
50/200 cross—
Supertrendup · 63.82
RSI (14)73
MACD hist0.37
MACD crossbull · 9d
Stoch %K / %D93 / 91
ADX (14)40
+DI / −DI31 / 13
RSI divergenceBearish
MACD divergence—
ATR %+5.35%
ADR %6.48%
52w high76.89
52w low12.00
From 52w high+0.00%
Above 52w low+540.75%
New 52w highYes
SqueezeOff
Bollinger width38.61%
%B0.89
Donchian pos95.26%
Donchian high78.08
Donchian low53.06
AVWAP (52w high)76.65
vs AVWAP high+0.31%
AVWAP (52w low)34.32
vs AVWAP low+124.03%
OBV trendUp
Chaikin MF (20)0.19
Today vs 20d4.22×
Avg vol (14d)3.58M
Avg vol (20d)3.08M
Avg $ vol (20d)213.65M
Market cap6.84B
RS 3m (vs SPY)+102.35%
RS 6m (vs SPY)+111.03%
RS line new highYes
Trend template8/8
Technical rank95.5
1 week+12.00%
1 month+27.95%
3 months+110.02%
6 months+114.90%
1 year+457.98%
YTD+144.87%
P/E-99.21
P/B62.97
P/S43.19
P/FCF-170.85
EPS-0.8000
Div yield—
ROE-63.48%
ROA-17.17%
Debt/Eq0.18
Current2.22
EV/EBITDA-133.10
Gross margin—
Net margin-43.53%
Rev growth1031.18%
EPS growth46.28%
Price target74.50
Target upside-3.11%
Analyst ratingBuy
Institutional73.96%
Ent. value6.63B
Revenue132.87M
Net income52.86M
Gross profit—
Free cash flow-40.02M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out88.93M
Employees216
ListedThu, Jul 26, 2018
Free float65.81M
Float %75.7%
Short interest9.96M
Days to cover7.8d
Short volume66.4%
Squeeze score88 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.52 vs $0.34
Last surprise+52.9% beat
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank95.5 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance70.00
Support38.53
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in LQDA
No recent disclosed trades by Congress in LQDA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in LQDA · 8 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Bloch Stephen M Director · Common Stock · 2026-06-22 | Sell | 69.5K | $5.3M | 2026-06-22 | 2026-06-24 |
Bloch Stephen M Director · Common Stock · 2026-06-22 | Sell | 30.5K | $2.3M | 2026-06-22 | 2026-06-24 |
deGoa Damian Director · Common Stock · 2026-06-16 | Grant | 5.88K | — | 2026-06-16 | 2026-06-18 |
KIRSCH ARTHUR S Director · Common Stock · 2026-06-16 | Grant | 5.88K | — | 2026-06-16 | 2026-06-18 |
Rielly-Gauvin Katherine Director · Common Stock · 2026-06-16 | Grant | 5.88K | — | 2026-06-16 | 2026-06-18 |
SINGH RAMAN Director · Common Stock · 2026-06-16 | Grant | 5.88K | — | 2026-06-16 | 2026-06-18 |
Manning Paul B Director · Common Stock · 2026-06-16 | Grant | 5.88K | — | 2026-06-16 | 2026-06-18 |
Horobin Joanna Director · Common Stock · 2026-06-16 | Grant | 5.88K | — | 2026-06-16 | 2026-06-18 |
Bloch Stephen M Director · Common Stock · 2026-06-16 | Grant | 5.88K | — | 2026-06-16 | 2026-06-18 |
JOHNSON DAVID EDWARD Director · Common Stock, $0.001 par value per share ("Common Stock") · 2026-06-16 | Grant | 5.88K | — | 2026-06-16 | 2026-06-18 |
SEC filings
EDGAR filings in LQDA · 8 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.